Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
biotech
4
×
life sciences
boston blog main
boston top stories
clinical trials
ipo
national blog main
new york blog main
new york top stories
acetylon pharmaceuticals
agios pharmaceuticals
ambys medicines
biologic drugs
boston xcon
boulder/denver xcon
cancer
cancer drugs
cell therapy
constellation pharmaceuticals
david e. shaw
deals
detroit xcon
digital health
drug development
drug discovery
drugdiscovery
enasidenib
fda
gene therapy
genentech
genome sequencing
healthtech
holger willenbring
indiana xcon
innovation
investing
investors
ivosidenib
jeffrey tong
juan carlos izpisua belmonte
What
medicines
4
×
today
4
×
development
aiming
ambys
appeared
big
biologic
biotech
bloomberg
bottleneck
clinical
company’s
control
course
deadly
deal
debuted
discover
diseases
dramatically
drug
emerging
experimental
fixing
formed
future
genomic
growing
handiwork
helped
internal
ipo
landscape
launch
liver
make
making
medicine
nature
Language
unset
Current search:
medicines
×
biotech
×
today
×
@envedabio
2 years ago
Today @wolfejosh appeared on Bloomberg @business @Quicktake & shared how we are turning nature into medicines along with what’s next for #investors in emerging technologies #biotech #drugdiscovery #AI #MachineLearning https://bloom.bg/3B7hj90
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority
